Cidara Therapeutics, Inc.
CDTX
Rang în acțiuni
#3185
Cidara Therapeutics, Inc. is a biotechnology company specializing in the... Cidara Therapeutics, Inc. is a biotechnology company specializing in the creation, advancement, and commercialization of extended-duration anti-infective drugs. Their mission targets the prevention and treatment of infectious diseases and certain cancers within the U.S. Their primary therapeutic candidate, rezafungin acetate, is an innovative echinocandin antifungal designed to combat and avert severe fungal infections such as candidemia and invasive candidiasis, conditions known for their high fatality rates. Additionally, Cidara utilizes its Cloudbreak platform to engineer conjugated therapies aimed at preventing and treating influenza as well as various other viral illnesses, including respiratory syncytial virus (RSV), human immunodeficiency virus (HIV), and SARS-CoV-2, the pathogen behind COVID-19. Originally incorporated in 2012 as K2 Therapeutics, Inc., the company adopted its current name, Cidara Therapeutics, Inc., in July 2014. Its operations are headquartered in San Diego, California.
Preț acțiune
$221.38
Ultima sincronizare: 2026-01-08
Capitalizare de piață
$5.61B
Schimbare (1 zi)
0.00%
Schimbare (1 an)
118.07%
Țară
US
Tranzacționează Cidara Therapeutics, Inc. (CDTX)
Categorie
Healthcare
Raport P/S pentru Cidara Therapeutics, Inc. (CDTX)
Raport P/S la data de October 2026 TTM: 0.00
Conform celor mai recente rapoarte financiare și prețului acțiunilor Cidara Therapeutics, Inc., raportul P/S actual (TTM) este 0.00. La sfârșitul anului 2023, compania avea un P/S de 1.09.
Istoricul raportului P/S pentru Cidara Therapeutics, Inc. din 2012 până în 2026
Raport P/S la sfârșitul fiecărui an
| An | Raport P/S | Schimbă |
|---|---|---|
| 2026 (TTM) | 0.00 | -100.00% |
| 2024 | 133.87 | 12,223.04% |
| 2023 | 1.09 | 32.15% |
| 2022 | 0.82 | -38.80% |
| 2021 | 1.34 | -80.50% |
| 2020 | 6.89 | 25.32% |
| 2019 | 5.50 | 0.00% |
| 2018 | 0.00 | 0.00% |
| 2017 | 0.00 | 0.00% |
| 2016 | 0.00 | 0.00% |
| 2015 | 0.00 | 0.00% |
| 2014 | 0.00 | 0.00% |
| 2013 | 0.00 | 0.00% |
| 2012 | 0.00 | 0.00% |
Raport P/S pentru companii similare sau competitoare
| Companie | Raport P/S | Diferență raport P/S | Țara |
|---|---|---|---|
| 10.02 | - |
US
|
|
| 40.55 | - |
US
|
|
| 3.96 | - |
AU
|
|
| - | - |
CH
|
|
| 10.15 | - |
NL
|
